Privi Speciality Chemicals
- P/E
- 36.60
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 22.30%
- Debt to Equity
- 0.72
- EPS (TTM)
- ₹89.47
- Book Value
- ₹403.23
- Market Cap
- —
- P/E (TTM)
- 36.60
- P/B
- 8.12
- ROE
- 26.00%
- Dividend Yield
- 0.15%
- EBITDA
- ₹666 Cr
- 52W High
- ₹3,785.30
- 52W Low
- ₹2,570.80
- Day Range
- ₹3,222.30 – ₹3,323.90
- Volume
- 1,19,827
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| ₹3,274.70 | 36.60 | ₹12,690 Cr | 8.12 | 0.15% | 26.00% | 22.30% | ₹2,671 Cr | ₹342 Cr | |
| Median 8 companies | ₹2,426.55 | 46.82 | ₹20,474 Cr | 6.96 | 0.19% | 10.66% | 13.40% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 68
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 32
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 71
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 49
- Average
- Solvency, leverage, coverage 9% weight
- Momentum
- 43
- Weak
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company has delivered good profit growth of 26.8% CAGR over last 5 years
Weaknesses
2- Stock is trading at 8.92 times its book value
- Promoter holding has decreased over last 3 years: -13.4%
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 10 | 7 | 2 |
| Oscillators | Bearish | 2 | 7 | 0 |
| Moving Averages | Strong Bearish | 8 | 0 | 2 |
Oscillators
Bearish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 43.17
- Neutral
- MACD (12,26,9)
- −48.78
- Bearish
- SMA (50)
- 3,431.39
- Bearish
- SMA (200)
- 3,260.82
- Bullish
As of
Analyst Rating
3 of 3 analysts rate Buy, 0 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 5Y | +14.96% |
|---|---|
| 3Y | +16.83% |
| 1Y | +22.04% |
| TTM | +21.62% |
Net profit
| 5Y | +22.06% |
|---|---|
| 3Y | +147.14% |
| 1Y | +71.35% |
| TTM | +62.09% |
Operating cash flow
| 5Y | +26.17% |
|---|---|
| 3Y | +123.90% |
| 1Y | +95.73% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | +8.95 pp |
|---|---|
| 3Y | +13.70 pp |
| 1Y | +3.59 pp |
| TTM | +2.68 pp |
Revenue by year
| Mar 2017 | ₹597 Cr |
|---|---|
| Mar 2018 | ₹1,024 Cr |
| Mar 2019 | ₹1,341 Cr |
| Mar 2020 | ₹1,631 Cr |
| Mar 2021 | ₹1,277 Cr |
| Mar 2022 | ₹1,404 Cr |
| Mar 2023 | ₹1,608 Cr |
| Mar 2024 | ₹1,752 Cr |
| Mar 2025 | ₹2,101 Cr |
| Mar 2026 | ₹2,564 Cr |
Net profit by year
| Mar 2017 | ₹27.00 Cr |
|---|---|
| Mar 2018 | ₹53.00 Cr |
| Mar 2019 | ₹94.00 Cr |
| Mar 2020 | ₹176 Cr |
| Mar 2021 | ₹117 Cr |
| Mar 2022 | ₹97.00 Cr |
| Mar 2023 | ₹21.00 Cr |
| Mar 2024 | ₹95.00 Cr |
| Mar 2025 | ₹185 Cr |
| Mar 2026 | ₹317 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Privi Speciality Chemicals Ltd trades at ₹3,296.3 as of 2026-10-29 with a market cap of ₹12,876 cr. The company has demonstrated strong profit growth (TTM profit growth of 61%) and an improving ROE of 22%, but trades at elevated valuations with a P/E of 36.84x and P/B of 9.12x, while promoter holding has declined by 13.4% over three years.
- TTM profit growth of 61% signals a sharp acceleration in earnings, well above the 5-year compounded profit CAGR of 27%
- ROE of 22% (last year 26%) is well above cost of equity for most Indian chemical companies, indicating efficient capital deployment
- ROCE of 25.11% reflects strong returns on total capital employed, suggesting pricing power and operational efficiency
- Compounded sales growth of 22% on a TTM basis indicates healthy top-line momentum alongside profit expansion
- 5-year compounded profit CAGR of 26.8% demonstrates sustained earnings growth over a meaningful period, not just a single-year spike
- 3-year stock CAGR of 40% reflects meaningful value creation for shareholders over the medium term
- Debt-to-equity ratio of 0.72 is manageable for a specialty chemicals company with capex needs, and the high ROCE suggests debt is being deployed productively
- P/E of 36.84x on TTM EPS of ₹89.47 is at a premium to many specialty chemical peers, leaving limited room for execution misses
- Stock trades at 9.12x book value, well above sector averages, pricing in significant future growth that must be delivered
- Promoter holding has decreased by 13.4% over the last three years, which may signal reduced insider confidence or dilution-related concerns
- Dividend yield of just 0.29% offers negligible income cushion, making returns entirely dependent on capital appreciation
- Stock is trading 12.9% below its 52-week high of ₹3,785.3, indicating recent selling pressure or waning momentum
- 10-year compounded sales and profit growth data is unavailable, limiting visibility into long-term cyclical performance through full industry downturns
- Debt-to-equity of 0.72 means the balance sheet carries meaningful leverage; a downturn in chemical demand or margin compression could strain debt servicing
- 5-year stock CAGR of 14% lags the 3-year CAGR of 40%, suggesting much of the re-rating is recent and may not be sustainable if growth normalizes
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Limited recent news flow for Privi Speciality Chemicals. The only development is a routine NCLT notice for merging two subsidiaries, which is a standard corporate restructuring step with no immediate financial impact. Outlook depends on broader chemical sector trends and upcoming quarterly results.
- NCLT merger notice received Oct 6
Privi Speciality Chemicals received an NCLT notice for amalgamation of two subsidiaries. Member meeting scheduled for October 27, 2026 to approve the scheme.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 409 | 455 | 404 | 484 | 464 | 533 | 491 | 614 | 559 | 679 | 605 | 722 | 666 | 760 |
| Expenses | 354 | 366 | 314 | 393 | 370 | 423 | 378 | 481 | 427 | 497 | 453 | 541 | 514 | 561 |
| Operating Profit | 55 | 89 | 90 | 91 | 94 | 110 | 113 | 133 | 132 | 182 | 151 | 180 | 152 | 200 |
| OPM % | 13% | 20% | 22% | 19% | 20% | 21% | 23% | 22% | 24% | 27% | 25% | 25% | 23% | 26% |
| Other Income | 6 | 7 | 6 | 8 | 3 | 4 | 2 | 15 | 9 | 0 | 7 | 4 | 15 | 13 |
| Interest | 24 | 25 | 24 | 25 | 22 | 22 | 22 | 23 | 24 | 21 | 19 | 18 | 17 | 17 |
| Depreciation | 31 | 31 | 32 | 30 | 32 | 32 | 32 | 35 | 36 | 36 | 36 | 36 | 37 | 37 |
| PBT | 6 | 40 | 39 | 44 | 43 | 61 | 61 | 90 | 81 | 125 | 104 | 130 | 113 | 159 |
| Tax % | 30% | 25% | 26% | 28% | 27% | 26% | 27% | 29% | 29% | 28% | 28% | 27% | 27% | 26% |
| Net Profit | 5 | 30 | 29 | 32 | 31 | 45 | 44 | 64 | 58 | 90 | 75 | 94 | 83 | 118 |
| EPS (₹) | 1.18 | 7.8 | 7.36 | 7.93 | 8.02 | 11.42 | 11.37 | 17.01 | 15.84 | 24.02 | 19.95 | 23.96 | 21.54 | — |
Sep 2026: from the results filed on 29 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 597 | 1,024 | 1,341 | 1,631 | 1,277 | 1,404 | 1,608 | 1,752 | 2,101 | 2,564 | 2,671 |
| Expenses | 525 | 894 | 1,128 | 1,362 | 1,067 | 1,209 | 1,420 | 1,423 | 1,643 | 1,912 | 2,005 |
| Operating Profit | 72 | 130 | 213 | 268 | 210 | 195 | 188 | 329 | 458 | 651 | 666 |
| OPM % | 12% | 13% | 16% | 16% | 16% | 14% | 12% | 19% | 22% | 25% | 25% |
| Other Income | 10 | 16 | 14 | 66 | 43 | 38 | 21 | 26 | 20.65 | 19 | 26 |
| Interest | 20 | 24 | 29 | 41 | 24 | 25 | 70 | 102 | 92 | 87 | 75 |
| Depreciation | 27 | 43 | 47 | 63 | 71 | 75 | 108 | 123 | 132 | 144 | 145 |
| PBT | 36 | 79 | 152 | 231 | 158 | 133 | 31 | 130 | 255 | 440 | 472 |
| Tax % | 24% | 32% | 38% | 24% | 26% | 27% | 31% | 27% | 27% | 28% | — |
| Net Profit | 27 | 53 | 94 | 176 | 117 | 97 | 21 | 95 | 185 | 317 | 342 |
| EPS (₹) | 7.21 | 14.19 | 24.1 | 45.1 | 29.9 | 24.91 | 5.68 | 24.27 | 47.83 | 83.77 | 89.47 |
| Div. Payout % | 14% | 11% | 10% | 3% | 7% | 8% | 0% | 8% | 10% | 12% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 38 | 38 | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 39 |
| Reserves | 406 | 451 | 537 | 702 | 683 | 773 | 790 | 885 | 1,064 | 1,373 |
| Borrowings | 321 | 330 | 491 | 569 | 537 | 933 | 1,079 | 1,008 | 1,143 | 1,021 |
| Other Liabilities | 174 | 235 | 359 | 294 | 281 | 431 | 483 | 410 | 544 | 736 |
| Total Liabilities | 939 | 1,053 | 1,426 | 1,604 | 1,540 | 2,176 | 2,391 | 2,343 | 2,791 | 3,170 |
| Fixed Assets | 388 | 437 | 498 | 725 | 598 | 704 | 1,017 | 1,034 | 1,156 | 1,169 |
| CWIP | 24 | 49 | 95 | 40 | 175 | 373 | 100 | 99 | 141 | 314 |
| Investments | 1 | 3 | 0 | 1 | 0 | 12 | 7 | 40 | 8 | 54 |
| Other Assets | 527 | 564 | 833 | 839 | 768 | 1,087 | 1,268 | 1,169 | 1,485 | 1,633 |
| Total Assets | 939 | 1,053 | 1,426 | 1,604 | 1,540 | 2,176 | 2,391 | 2,343 | 2,791 | 3,170 |
Cash Flow
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 17 | 107 | 21 | 247 | 172 | 5 | 49 | 354 | 281 | 550 |
| Investing | 80 | −81 | −139 | −206 | −242 | −321 | −133 | −180 | −294 | −358 |
| Financing | −89 | −20 | 122 | 27 | 0 | 333 | 72 | −171 | 39 | −198 |
| Net Cash Flow | 7 | 5 | 4 | 68 | −69 | 17 | −12 | 4 | 26 | −6 |
| Free Cash Flow | 17 | 107 | 46 | 37 | −71 | −304 | −91 | 212 | −17 | 230 |
| CFO/EBITDA | 49 | 96 | 24 | 120 | 101 | 19 | 33 | 116 | 77 | 102 |
Ratios
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 106 | 82 | 90 | 60 | 68 | 69 | 67 | 72 | 68 | 75 |
| Inventory Days | 236 | 132 | 162 | 135 | 170 | 279 | 311 | 245 | 262 | 235 |
| Days Payable | 115 | 85 | 95 | 55 | 83 | 138 | 114 | 105 | 134 | 150 |
| Cash Conversion Cycle | 227 | 129 | 157 | 139 | 155 | 209 | 264 | 212 | 197 | 160 |
| Working Capital Days | 31 | 20 | 40 | 45 | 65 | 19 | 16 | 37 | 35 | 54 |
| ROCE % | — | 13% | 18% | 20% | 12% | 10% | 6% | 12% | 16% | 22% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Privi Speciality Chemicals insights
64 extracted metrics across FY10–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Concall · May 2026Transcript PPT Recording
- Q3 FY26 concall · Feb 2026Transcript PPT Recording
- Q2 FY26 concall · Nov 2025Transcript PPT Recording
- 30 Jun 2026
- 20 Apr 2026
- 10 Mar 2025
- 21 May 2024
- 20 Sep 2023
- General announcements 30 Oct 2026
Frequently Asked Questions about Privi Speciality Chemicals
What does Privi Speciality Chemicals Ltd do?
Where is Privi Speciality Chemicals Ltd (PRIVISCL) listed?
Which sector does Privi Speciality Chemicals Ltd belong to?
What is the PE ratio of Privi Speciality Chemicals Ltd?
What is the 52-week high and low of Privi Speciality Chemicals Ltd?
Does Privi Speciality Chemicals Ltd pay dividends?
What is the Return on Equity (ROE) of Privi Speciality Chemicals Ltd?
Company Information
Incorporated in 1985, Privi Speciality Chemicals Ltd (Formerly known as Privi Speciality Ltd.) is primarily engaged in the manufacturing, supply and exports of aroma and fragrance chemicals used in soaps, detergents, shampoos, and other fine fragrances.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/PRIVISCL.md for Privi Speciality Chemicals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.